Suppr超能文献

[口服低剂量普萘洛尔对血管瘤婴儿动态心电图结果的影响]

[Changes in ambulatory electrocardiographic findings after oral administration of low-dose propranolol in infants with hemangioma].

作者信息

Yi Lan-Fen, Wen Hong-Xia, Huang Sui, Qiu Mei, Zhang Jing-Yang, Cao Xiao-Xiao

机构信息

Department of Electrocardiogram, Wuhan Medical Health Care Center for Women and Children/Wuhan Children's Hospital/Wuhan Maternal and Child Health Care Hospital, Wuhan 430016, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2016 Apr;18(4):345-9. doi: 10.7499/j.issn.1008-8830.2016.04.013.

Abstract

OBJECTIVE

To investigate the effects of oral administration of low-dose propranolol on heart rate variability (HRV), acceleration capacity (AC), deceleration capacity (DC), and cardiac conduction in the treatment of infantile hemangioma.

METHODS

A total of 118 infants with hemangioma (≤1 year) were enrolled, and 24-hour ambulatory electrocardiography was performed before oral administration of low-dose propranolol and after one month of administration. The changes in time-domain indices [standard deviation of all normal sinus RR intervals (SDNN), standard deviation of all mean 5-minute RR intervals (SDANN), root mean squared successive difference (RMSSD), and percentage of successive normal sinus RR intervals >50 ms (PNN50)] and frequency-domain indices [low frequency (LF) and high frequency (HF)] for HRV, AC, and DC were observed, as well as abnormalities in cardiac conduction and other aspects after administration of propranolol.

RESULTS

After administration of propranolol, the infants had significantly increased SDNN, RMSSD, LF, HF, and PNN50 (P<0.01), and significantly reduced AC, mean heart rate (HR) and minimum HR (P<0.01). The 24-hour ambulatory electrocardiographic findings showed a nonsignificantly higher abnormal rate after administration of propranolol.

CONCLUSIONS

In the treatment of infantile hemangioma, propranolol can inhibit the activity of sympathetic nerve and block cardiac conduction, but without any serious adverse effect.

摘要

目的

探讨口服低剂量普萘洛尔对婴儿血管瘤治疗中心率变异性(HRV)、加速能力(AC)、减速能力(DC)及心脏传导的影响。

方法

共纳入118例年龄≤1岁的血管瘤婴儿,在口服低剂量普萘洛尔前及给药1个月后进行24小时动态心电图检查。观察HRV、AC和DC的时域指标[所有正常窦性RR间期的标准差(SDNN)、所有平均5分钟RR间期的标准差(SDANN)、相邻RR间期差值的均方根(RMSSD)以及相邻正常窦性RR间期>50 ms的百分比(PNN50)]和频域指标[低频(LF)和高频(HF)],以及普萘洛尔给药后心脏传导和其他方面的异常情况。

结果

普萘洛尔给药后,婴儿的SDNN、RMSSD、LF、HF和PNN50显著增加(P<0.01),AC、平均心率(HR)和最低HR显著降低(P<0.01)。24小时动态心电图检查结果显示,普萘洛尔给药后异常率略有升高,但差异无统计学意义。

结论

在婴儿血管瘤治疗中,普萘洛尔可抑制交感神经活性并阻滞心脏传导,但无严重不良反应。

相似文献

1
[Changes in ambulatory electrocardiographic findings after oral administration of low-dose propranolol in infants with hemangioma].
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Apr;18(4):345-9. doi: 10.7499/j.issn.1008-8830.2016.04.013.
2
[Correlations of thyroid hormone with deceleration capacity of heart rate and heart rate variability in children with hyperthyroidism].
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Oct;20(10):814-818. doi: 10.7499/j.issn.1008-8830.2018.10.006.
7
Changes of deceleration and acceleration capacity of heart rate in patients with acute hemispheric ischemic stroke.
Clin Interv Aging. 2016 Mar 11;11:293-8. doi: 10.2147/CIA.S99542. eCollection 2016.
8
Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades.
J Am Coll Cardiol. 1998 Mar 1;31(3):593-601. doi: 10.1016/s0735-1097(97)00554-8.
10
[Cardiac autonomic nerve function in obese school-age children].
Zhongguo Dang Dai Er Ke Za Zhi. 2017 May;19(5):524-528. doi: 10.7499/j.issn.1008-8830.2017.05.009.

引用本文的文献

2
[An analysis of cardiac autonomic nerve function in girls with idiopathic central precocious puberty].
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Dec;19(12):1239-1242. doi: 10.7499/j.issn.1008-8830.2017.12.003.
3
[Cardiac autonomic nerve function in obese school-age children].
Zhongguo Dang Dai Er Ke Za Zhi. 2017 May;19(5):524-528. doi: 10.7499/j.issn.1008-8830.2017.05.009.

本文引用的文献

1
2
Propranolol therapy for infantile hemangioma.
Indian Pediatr. 2013 Mar;50(3):307-13. doi: 10.1007/s13312-013-0098-9.
3
Propranolol and infantile hemangiomas four years later: a systematic review.
Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91. doi: 10.1111/pde.12089. Epub 2013 Feb 14.
4
Propranolol as first-line treatment for infantile hemangiomas.
Plast Reconstr Surg. 2010 Jan;125(1):420-421. doi: 10.1097/PRS.0b013e3181c2a731.
5
Propranolol for severe hemangiomas of infancy.
N Engl J Med. 2008 Jun 12;358(24):2649-51. doi: 10.1056/NEJMc0708819.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验